Jointown Pharmaceutical Group
12
20M
9
0.48
2
0.25
- Areas of investment
Summary
Jointown Pharmaceutical Group is the famous Corporate Investor, which was founded in 1999. The venture was found in Asia in China. The main office of represented Corporate Investor is situated in the Wuhan.
The high activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Jointown Pharmaceutical Group, startups are often financed by Lighthouse Capital Management, Shunwei Capital, Lilly Asia Ventures. The meaningful sponsors for the fund in investment in the same round are Shunwei Capital, Lighthouse Capital Management, Fosun Group. In the next rounds fund is usually obtained by Shunwei Capital, Lighthouse Capital Management, Fosun Group.
Among the most popular portfolio startups of the fund, we may highlight Singlera Genomics, Hipac.cn. Among the most popular fund investment industries, there are Medical, Apps. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 12
- Lead investments
- 2
- Rounds per year
- 0.48
- Follow on index
- 0.25
- Investments by industry
- Medical (6)
- Online Portals (3)
- Biotechnology (3)
- Health Care (3)
- E-Commerce (3) Show 15 more
- Investments by region
-
- China (11)
- United States (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 0.92
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Convalife Pharmaceuticals | 03 Jan 2023 | Medical, Pharmaceutical, Biopharma | Early Stage Venture | 15M | Shanghai, Shanghai, China |
| Quartet Health | 14 Apr 2016 | Information Technology, Health Care, Hospital, Personal Health, Predictive Analytics | Early Stage Venture | 40M | United States, New York, New York |
| Singlera Genomics | 27 Mar 2018 | Biotechnology, Health Care, Health Diagnostics, Genetics, Medical | Early Stage Venture | 60M | United States, California, San Diego |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.